Hoth Therapeutics (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies for underserved ...

(RTTNews) - Hoth Therapeutics (HOTH) announced its collaboration with OnTargetx R&D to advance research for its cancer-fighting therapeutic, HT-KIT. The study focuses on: development and optimization ...

Hoth Therapeutics (HOTH) announced the filing of two U.S. provisional patent applications that significantly expand the Company’s intellectual ...

Hoth Therapeutics filed two provisional patent applications with the U.S. Patent and Trademark Office, expanding the ...

Hoth Therapeutics (HOTH) responded to recent market rumors and inquiries from shareholders regarding its financial plans and ongoing clinical trials. The company affirms that it has no plans for a ...

Hoth Therapeutics has filed two U.S. provisional patent applications that significantly expand its intellectual property ...

Investing.com -- Hoth Therapeutics Inc (NASDAQ:HOTH) stock rose 5.1% in Friday’s premarket trading after the clinical-stage biopharmaceutical company announced the filing of two U.S. provisional ...

Star Wars creatures, critters, and robots get lots of appreciation, but what about the imaginative carriages that make all the heroes’ galaxy jetting possible? With Star Wars Wars, The A.V. Club ...

Hoth Therapeutics Inc., a micro-cap biotech company, saw its stock price surge over 200% on Tuesday to become the top gainer across U.S. exchanges. Trading volume skyrocketed to 665 times its daily ...

NEW YORK, Feb. 10, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company dedicated to developing innovative therapies for unmet medical needs, today announced its ...

HT-KIT triggered significant tumor cell death in preclinical models of gastrointestinal stromal tumors (GIST) and systemic mastocytosis as early as 24 hours post-treatment, with statistically ...